Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The prediction had a final performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | -8.831% | -8.831% | 12.520% | -6.953% |
| iShares Core DAX® | -2.116% | -8.178% | -1.471% | 54.145% |
| iShares Nasdaq 100 | -1.132% | 0.908% | 19.961% | 83.323% |
| iShares Nikkei 225® | -0.658% | -6.257% | 27.473% | 53.605% |
| iShares S&P 500 | -1.261% | -1.001% | 13.631% | 62.624% |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year